Format

Send to

Choose Destination
Mol Ther. 2018 Sep 5;26(9):2081-2082. doi: 10.1016/j.ymthe.2018.08.003. Epub 2018 Aug 11.

Breaking and Sealing Barriers in Retinal Gene Therapy.

Author information

1
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA; Grousbeck Gene Therapy Center, Ocular Genomics Institute, Massachusetts Eye and Ear, Boston, MA, USA; Berman-Gund Laboratory for Retinal Degeneration, Massachusetts Eye and Ear, Boston, MA, USA. Electronic address: joan_miller@meei.harvard.edu.
2
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA; Grousbeck Gene Therapy Center, Ocular Genomics Institute, Massachusetts Eye and Ear, Boston, MA, USA; Berman-Gund Laboratory for Retinal Degeneration, Massachusetts Eye and Ear, Boston, MA, USA; The Broad Institute of Harvard and MIT, Cambridge, MA, USA. Electronic address: luk_vandenberghe@meei.harvard.edu.
PMID:
30107998
PMCID:
PMC6127874
[Available on 2019-09-05]
DOI:
10.1016/j.ymthe.2018.08.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center